Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Veracyte Inc (NASDAQ:VCYT)

9.00
Delayed Data
As of Mar 22
 -0.04 / -0.44%
Today’s Change
4.21
Today|||52-Week Range
9.61
+16.28%
Year-to-Date
No recent news for Veracyte Inc.

Today’s Trading

Previous close9.04
Today’s open9.02
Day’s range8.80 - 9.15
Volume91,872
Average volume (3 months)145,962
Market cap$306.0M
Dividend yield--
Data as of 03/22/2017

Growth & Valuation

Earnings growth (last year)+16.15%
Earnings growth (this year)+21.87%
Earnings growth (next 5 years)--
Revenue growth (last year)+31.48%
P/E ratioNM
Price/Sales3.43
Price/Book5.12

Competitors

 Today’s
change
Today’s
% change
CALACalithera Bioscience...-0.25-2.37%
OXFDOxford Immunotec Glo...+0.13+0.85%
CLDXCelldex Therapeutics...+0.07+2.21%
QTNTQuotient Ltd+0.18+2.79%
Data as of 03/22/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$65.1M
Annual profit (last year)-$31.4M
Net profit margin-48.18%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Bonnie H. Anderson
President &
Chief Operating Officer
Christopher M. Hall
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs